Abstract:IntroductionThe coronavirus disease 2019 (COVID-19) pandemic has affected billions of people worldwide, and the lessons learned need to be concluded to get better prepared for the next pandemic. Early identification of high-risk patients is important for appropriate treatment and distribution of medical resources. A generalizable and easy-to-use COVID-19 severity stratification model is vital and may provide references for clinicians.MethodsThree COVID-19 cohorts (one discovery cohort and two validation cohorts) were included. Longitudinal peripheral blood mononuclear cells were collected from the discovery cohort (n = 39, mild = 15, critical = 24). The immune characteristics of COVID-19 and critical COVID-19 were analyzed by comparison with those of healthy volunteers (n = 16) and patients with mild COVID-19 using mass cytometry by time of flight (CyTOF). Subsequently, machine learning models were developed based on immune signatures and the most valuable laboratory parameters that performed well in distinguishing mild from critical cases. Finally, single-cell RNA sequencing data from a published study (n = 43) and electronic health records from a prospective cohort study (n = 840) were used to verify the role of crucial clinical laboratory and immune signature parameters in the stratification of COVID-19 severity.ResultsPatients with COVID-19 were determined with disturbed glucose and tryptophan metabolism in two major innate immune clusters. Critical patients were further characterized by significant depletion of classical dendritic cells (cDCs), regulatory T cells (Tregs), and CD4+ central memory T cells (Tcm), along with increased systemic interleukin-6 (IL-6), interleukin-12 (IL-12), and lactate dehydrogenase (LDH). The machine learning models based on the level of cDCs and LDH showed great potential for predicting critical cases. The model performances in severity stratification were validated in two cohorts (AUC = 0.77 and 0.88, respectively) infected with different strains in different periods. The reference limits of cDCs and LDH as biomarkers for predicting critical COVID-19 were 1.2% and 270.5 U/L, respectively.ConclusionOverall, we developed and validated a generalizable and easy-to-use COVID-19 severity stratification model using machine learning algorithms. The level of cDCs and LDH will assist clinicians in making quick decisions during future pandemics.

Multi-omics and Immune Cells’ Profiling of COVID-19 Patients for ICU Admission Prediction: in Silico Analysis and an Integrated Machine Learning-Based Approach in the Framework of Predictive, Preventive, and Personalized Medicine

A Tri-Light Warning System for Hospitalized COVID-19 Patients: Credibility-based Risk Stratification for Future Pandemic Preparedness

A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province, China

Simple Nomogram Based on Initial Laboratory Data for Predicting the Probability of ICU Transfer of COVID‐19 Patients: Multicenter Retrospective Study

Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes

Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study

A robust and parsimonious machine learning method to predict ICU admission of COVID-19 patients

A Generalizable and Easy-to-use COVID-19 Stratification Model for the Next Pandemic Via Immune-Phenotyping and Machine Learning

Using machine learning in prediction of ICU admission, mortality, and length of stay in the early stage of admission of COVID-19 patients

Integrative Analysis for COVID-19 Patient Outcome Prediction

Development and validation of a prognostic model based on clinical laboratory biomarkers to predict admission to ICU in Omicron variant-infected hospitalized patients complicated with myocardial injury

CT-based Rapid Triage of COVID-19 Patients: Risk Prediction and Progression Estimation of ICU Admission, Mechanical Ventilation, and Death of Hospitalized Patients

Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology

Using Machine Learning to Predict Mortality for COVID-19 Patients on Day 0 in the ICU

Machine learning approaches to predict the need for intensive care unit admission among Iranian COVID-19 patients based on ICD-10: A cross-sectional study

Assessing the prognostic utility of clinical and radiomic features for COVID-19 patients admitted to ICU: challenges and lessons learned

Statistical Analysis and Machine Learning Prediction of Disease Outcomes for COVID-19 and Pneumonia Patients

Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores

A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile

A nomogram prediction of outcome in patients with COVID‐19 based on individual characteristics incorporating immune response‐related indicators

Integrated Clinical and CT Based Artificial Intelligence Nomogram for Predicting Severity and Need for Ventilator Support in COVID-19 Patients: A Multi-Site Study